Vaxcyte Inc [PCVX] stock is trading at $115.49, up 2.10%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PCVX shares have gain 3.35% over the last week, with a monthly amount glided 1.09%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Vaxcyte Inc [NASDAQ: PCVX] stock has seen the most recent analyst activity on December 07, 2023, when Mizuho initiated its Buy rating and assigned the stock a price target of $69. On January 03, 2023, Needham reiterated its Buy rating and revised its price target to $58 on the stock. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $66 on December 15, 2022. BTIG Research initiated its recommendation with a Buy and recommended $69 as its price target on November 17, 2022.
Vaxcyte Inc [PCVX] stock has fluctuated between $45.00 and $121.06 over the past year. Currently, Wall Street analysts expect the stock to reach $124.14 within the next 12 months. Vaxcyte Inc [NASDAQ: PCVX] shares were valued at $115.49 at the most recent close of the market. An investor can expect a potential return of 7.49% based on the average PCVX price forecast.
Analyzing the PCVX fundamentals
Gross Profit Margin for this corporation currently stands at 0.17% with Operating Profit Margin at -34.76%, Pretax Profit Margin comes in at -34.42%, and Net Profit Margin reading is -34.42%. To continue investigating profitability, this company’s Return on Assets is posted at -0.24, Equity is -0.3 and Total Capital is -0.25. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 113.37 points at the first support level, and at 111.24 for the second support level. However, for the 1st resistance point, the stock is sitting at 117.10, and for the 2nd resistance point, it is at 118.70.
Ratios To Look Out For
For context, Vaxcyte Inc’s Current Ratio is 17.88. Also, the Quick Ratio is 17.88, while the Cash Ratio stands at 6.26.
Transactions by insiders
Recent insider trading involved PICKERING GRANT, CHIEF EXECUTIVE OFFICER, that happened on Oct 07 ’24 when 7098.0 shares were sold. SVP, GEN COUNSEL & CORP SEC, Eydelman Mikhail completed a deal on Oct 07 ’24 to sell 5000.0 shares. Meanwhile, Officer PICKERING GRANT bought 7098.0 shares on Oct 07 ’24.
